RT Journal Article
SR Electronic
T1 DOES QUALITY OF COUNSELING AND EXPOSURE TO FAMILY PLANNING MESSAGES INFLUENCE THE USE OF MODERN CONTRACEPTIVES AMONG WOMEN IN NORTHERN NIGERIA?
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2024.04.03.24305214
DO 10.1101/2024.04.03.24305214
A1 Alabi, Matthew
A1 Dougherty, Leanne
A1 Etim, Eno-Obong
A1 Adedimeji, Adebola
YR 2024
UL http://medrxiv.org/content/early/2024/04/03/2024.04.03.24305214.abstract
AB Background Family Planning Counselling (FPC) involves information exchange on contraceptive methods between a provider and client and providing appropriate support in choosing a method that best suits the client’s needs. Access to sexual and reproductive health information enables women to make informed health decisions. However, the low modern contraceptive prevalence among women in northern Nigeria may be attributed to poor FPC and exposure to FP messages, among other factors. This study examines the impact of quality FPC and exposure to FP messages on modern contraceptive use.Methods We conducted a cross-sectional survey of 676 family planning clients aged 15-49 from 163 health facilities in Northern Nigeria. Quantitative data were collected using client exit interviews. The analysis included a binary logistic regression to predict the odds of modern contraceptive use using MII Plus and other explanatory variables.Result Only 29% received quality counselling about methods, while 35% were exposed to FP messages. The quality of counselling assessed using MII Plus did not predict modern contraceptive use. However, higher odds of using modern contraceptives were found among clients who reported their provider asked about their previous family planning experience (aOR=3.81; 95% CI: 1.04-13.99) and explained how the selected FP method works (aOR=5.51; 95% CI: 1.11-27.30). Clients who received FP messages from a place of worship (aOR=11.97; 95% CI: 1.76-81.62) and a community ruler (aOR=6.52; 95% CI: 1.02-41.58) had higher odds of using modern contraceptives.Conclusion Improving the quality of FPC and expanding exposure to FP messages through effective community structure can enhance the uptake of modern contraceptives in northern Nigeria.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe Bill & Melinda Gates Foundation funded the study. The findings and conclusions arrived at reflect those of the authors and not the positions of the Bill and Melinda Gates Foundation.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study sought and received approval from the Population Council Institutional Review Board (Protocol Number 992). In Nigeria, ethical approval to conduct the study was obtained at the national and state levels. At the national level, approval was granted by the National Health Research Ethics Committee with approval number NHREC/01/01/2007-17/01/2022, while the State Health and Research Ethics Board in each of the study sites provided approval at the state level. Informed consent was presented to the study participants to read and either sign or thumbprint to give their consent. Thus, only caregivers who gave their consent were interviewed.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors